Azacitidine (AZA) with Nivolumab (Nivo), and AZA with Nivo plus Ipilimumab (Ipi) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Prospective, Phase 2 Study

被引：35

作者：

Daver, Naval G. ^{[1
]}

Garcia-Manero, Guillermo ^{[2
]}

Konopleva, Marina Y. ^{[2
]}

Alfayez, Mansour ^{[2
]}

Pemmaraju, Naveen ^{[2
]}

Kadia, Tapan M. ^{[1
]}

DiNardo, Courtney D. ^{[2
]}

Cortes, Jorge E. ^{[2
]}

Ravandi, Farhad ^{[2
]}

Abbas, Hussein ^{[3
]}

Basu, Sreyashi ^{[4
]}

Jabbour, Elias ^{[2
]}

Pierce, Sherry A. ^{[2
]}

Estrov, Zeev E. ^{[2
]}

Takahashi, Koichi ^{[2
]}

Ning, Jing ^{[5
]}

Kornblau, Steven M. ^{[6
]}

Sasaki, Koji ^{[1
]}

Masarova, Lucia ^{[2
]}

Flores, Wilmer ^{[2
]}

Allison, James P. ^{[4
]}

Sharma, Padmanee ^{[4
]}

Kantarjian, Hagop M. ^{[2
]}

机构：

[1] Univ Texas Houston, MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[3] Univ Texas Houston, MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd, Houston, TX 77030 USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

[6] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Houston, TX 77030 USA

来源：

关键词：

D O I：

10.1182/blood-2019-131494

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

830

引用

页数：5